ALL-424 Updated Results from the Phase II Study of Blinatumomab in Combination With Ponatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Fadi G. Haddad, Hagop Kantarjian, Nicholas J. Short, Marina Konopleva, Nitin Jain, Xuelin Huang, Farhad Ravandi, William Wierda, Gautam Borthakur, Koji Sasaki, Ghayas Issa, Yesid Alvarado, Naveen Pemmaraju, Guillermo Garcia-Manero, Jennifer Thankachan, Rebecca Garris, Elias Jabbour

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'ALL-424 Updated Results from the Phase II Study of Blinatumomab in Combination With Ponatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences